Trial Profile
Evaluation of the Effects on Efficiency of a Sedation Service by Switching From Propofol to Dexmedetomidine
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Jul 2021
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Propofol (Primary)
- Indications Sedation
- Focus Therapeutic Use
- 06 Jul 2021 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified Jul 2019).
- 23 Jul 2019 Planned End Date changed from 31 Mar 2019 to 30 Sep 2019.
- 23 Jul 2019 Planned primary completion date changed from 31 Dec 2018 to 30 Sep 2019.